Source BioScience and Oxford Gene Technology Collaborate to Deliver Market-leading Next-generation Sequencing Service
On 1st September 2015, Source BioScience (LSE: SBS), the international laboratory services and products business, acquired the next-generation sequencing services business from Oxford Gene Technology (‘OGT’).
Following a series of successful acquisitions in recent years, Source BioScience has continued to expand and increase its products and services portfolio. The transfer of business from OGT to Source BioScience is hoped to contribute to the continued success and organic growth of the Company.
Dr Nick Ash, CEO of Source BioScience commented: “We are dedicated to delivering the highest-quality service to our customers and have made significant investment in our genomics and next-generation sequencing capability over a number of years. During that period we have forged a strong relationship with OGT and worked together on a number of projects. This most recent collaboration will enable customers to benefit from cutting-edge laboratory services from Source BioScience in conjunction with OGT’s leading analysis software.”
A provider of genetics research solutions, OGT has seen significant growth in its genomics products portfolio of late, and has, therefore, refocused its strategy to fuel further growth in the products business.
Mike Evans, CEO of OGT commented: “We will be providing our genetics analysis service customers with a high calibre alternative to OGT. We have worked closely with Source BioScience, well known as a trusted provider of state-of-the-art laboratory services, to ensure our customers will continue to receive best-in-class service and support, coupled with a seamless transition. Furthermore, OGT’s analysis software will be licensed to Source BioScience as part of the transfer, allowing customers continued access to the consistent, high quality, genetic analysis that OGT provides.”
For more information, please contact:
Source BioScience plc
Tel: +44 (0) 115 973 9012